Chan, S. L., Tan, B. R., Jimenez, E., Yen, C., Waszak, A., Dong, Y., D'Souza, J., Dhar, A. (2025). AMBER part 2F: Cobolimab in combination with dostarlimab in treatment-naïve patients with locally advanced/metastatic and/or unresectable hepatocellular carcinoma (HCC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.4_suppl.tps650